HomeCompareMBXBF vs GBDC

MBXBF vs GBDC: Dividend Comparison 2026

MBXBF yields 1162.79% · GBDC yields 11.86%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MBXBF wins by $71037527.50M in total portfolio value
10 years
MBXBF
MBXBF
● Live price
1162.79%
Share price
$0.17
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$71037548.35M
Annual income
$60,758,695,090,499.19
Full MBXBF calculator →
GBDC
GBDC
● Live price
11.86%
Share price
$12.65
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.85M
Annual income
$16,450,733.83
Full GBDC calculator →

Portfolio growth — MBXBF vs GBDC

📍 MBXBF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMBXBFGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MBXBF + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MBXBF pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MBXBF
Annual income on $10K today (after 15% tax)
$98,837.21/yr
After 10yr DRIP, annual income (after tax)
$51,644,890,826,924.31/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.91/yr
After 10yr DRIP, annual income (after tax)
$13,983,123.76/yr
At 15% tax rate, MBXBF beats the other by $51,644,876,843,800.55/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MBXBF + GBDC for your $10,000?

MBXBF: 50%GBDC: 50%
100% GBDC50/50100% MBXBF
Portfolio after 10yr
$35518784.60M
Annual income
$30,379,355,770,616.52/yr
Blended yield
85.53%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

MBXBF
No analyst data
Altman Z
1.4
Piotroski
2/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.7% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MBXBF buys
0
GBDC buys
0
No recent congressional trades found for MBXBF or GBDC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMBXBFGBDC
Forward yield1162.79%11.86%
Annual dividend / share$2.00$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.1%
Portfolio after 10y$71037548.35M$20.85M
Annual income after 10y$60,758,695,090,499.19$16,450,733.83
Total dividends collected$70267668.95M$20.43M
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: MBXBF vs GBDC ($10,000, DRIP)

YearMBXBF PortfolioMBXBF Income/yrGBDC PortfolioGBDC Income/yrGap
1← crossover$126,979$116,279.07$12,492$1,791.70+$114.5KMBXBF
2$1,515,775$1,379,907.30$16,527$3,160.58+$1.50MMBXBF
3$17,016,490$15,394,610.53$23,588$5,904.90+$16.99MMBXBF
4$179,725,369$161,517,725.51$37,141$11,901.65+$179.69MMBXBF
5$1,786,627,353$1,594,321,207.48$66,205$26,463.38+$1786.56MMBXBF
6$16,723,791,389$14,812,100,121.30$137,452$66,612.65+$16723.65MMBXBF
7$147,473,158,468$129,578,701,682.00$342,372$195,298.53+$147472.82MMBXBF
8$1,225,690,132,710$1,067,893,853,149.49$1,053,292$686,954.33+$1225689.08MMBXBF
9$9,606,404,914,243$8,294,916,472,243.00$4,111,439$2,984,416.95+$9606400.80MMBXBF
10$71,037,548,348,739$60,758,695,090,499.19$20,849,974$16,450,733.83+$71037527.50MMBXBF

MBXBF vs GBDC: Complete Analysis 2026

MBXBFStock

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. It manufactures a range of critical biological materials for the diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment and proficiency (QAPs) that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows. The company also applies its biological expertise and infrastructure to develop other proprietary products, primarily viral transport medium (DxTM) to stabilize patient samples for lab-based testing and Kinlytic Urokinase, a biologic thrombolytic drug used to treat blood clots. It sells QAPs to lab accreditation organizations, diagnostics companies, and clinical labs through a network of regional distributors. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.

Full MBXBF Calculator →

GBDCBDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this MBXBF vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MBXBF vs SCHDMBXBF vs JEPIMBXBF vs OMBXBF vs KOMBXBF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.